In the BioHarmony Drug Report Database
Romiplostim
Nplate (romiplostim) is a protein pharmaceutical. Romiplostim was first approved as Nplate on 2008-08-22. It is used to treat thrombocytopenic purpura idiopathic in the USA. It has been approved in Europe to treat thrombocytopenic purpura idiopathic. The pharmaceutical is active against thrombopoietin receptor.
Trade Name
|
Nplate |
|---|---|
Common Name
|
romiplostim |
ChEMBL ID
|
CHEMBL1201832 |
Indication
|
thrombocytopenic purpura idiopathic |
Drug Class
|
Colony-stimulating factors |
Image (chem structure or protein)
